Cytodyn Inc (CYDY)

[weasel6667]

I would guess they try to legitimate as much bonus as possible before we uplist to a serious stock exchange. After uplisting they are not able to blatantly grab into the cookie jar as they did in the past.

Looking back a few months, Nader and the BOD have already a history of questionable self servicing at the costs of the shareholders where the company was in desperate needs of funding. This should be addressed at one point.
I am still feed up with the whole Pestell story. Not alone that Nader and the BOD awarded them lots of bonuses and shares for this mess, it also cost us valuable time in the cancer section, since Nader dropped the ball on the cancer story. It also not in the interest of the shareholders to cut back or limit the development of Leronlimab because of "lack or limited funds" or in other words, the money is needed to compensate management instead of going on full speed with Leronlimab.

I have no problem with compensating management, but it must be at appropriate terms and amounts.

No wonder we do not pass the sniff test of any serious company. One of the first thing they probably do is to look in our books and for what we spend money.